MedTrace Logo

Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy

NCT06393309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 169

Last updated 2024-05-02

No results posted yet for this study

Summary

This study aimed to compare the long-term efficacy and safety of levetiracetam and valproate in treatment of idiopathic generalized epilepsy.

Conditions

  • Treatment of Idiopathic Generalized Epilepsy

Interventions

DRUG

Levetiracetam

Patients with idiopathic generalized epilepsy who were under treatment with levetiracetam

DRUG

Sodium valproate

Patients with idiopathic generalized epilepsy who were under treatment with valproate

Sponsors & Collaborators

  • Mazandaran University of Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-03
Primary Completion
2024-03-19
Completion
2024-03-19

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06393309 on ClinicalTrials.gov